Fundraising Fox

Eurazeo2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Rydoorydoo.cominJun 2024✓ verified

Rydoo provides an expense management platform that digitizes and automates expensing, reimbursement, and reporting processes for businesses.

Enterprise SoftwareFintechSaaS

Sebastien Marchon(CEO)Aidana Zhakupbekova(CFO)Fernando Amaral(CRO)Delphine Callens(CCO)Sebastian Vanhecke(CPO)

Co-investorsAdelie

Alt Mobilityalt-mobility.comin𝕏Nov 2024 · $10M

Alt Mobility provides electric vehicle leasing and asset management services for businesses and individuals in India.

CleantechClimate TechLogistics & Supply ChainMobility & Transportation

Dev Arora(Founder)in

Co-investorsAlteria CapitalBeyond Capital VenturesLVX VenturesNewRadioVenturePitchRight VenturesSprint Vc+1 more

Aqemiaaqemia.cominFeb 2024

Aqemia applies atomic-scale physics and generative AI to accelerate drug discovery and molecular design, enabling faster identification of innovative medicines for unmet therapeutic needs.

AI & Machine LearningBiotechDeep Tech

Maximilien Levesque(PhD, Prof., CEO and Co-Founder)Emmanuelle Martiano-Rolland(COO and Co-Founder)

Co-investorsCathay InnovationElaiaPSL Innovation FundBpifrance

Berkemgroupeberkem.cominJul 2024

Groupe Berkem is a chemical manufacturer developing plant-based and eco-responsible chemistry solutions to replace conventional chemical substances.

Circular EconomyCleantechNew Materials

Co-investorsM Capital Partners

Vico Therapeuticsvicotx.comJan 2024

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Luc Dochez(Chair and Founder)Josh Mandel-Brehm(Co-Founder)

Co-investorsDroia VenturesKurma PartnersPureos BioventuresEQT Life SciencesSeroba Life SciencesIdinvest Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.